Skip to search formSkip to main contentSkip to account menu

leridistim

Known as: 14-125 interleukin-3(14-alanine, 50-aspartic acid), granulocyte colony stimulating factor(17-serine) fusion protein, MPO, Myelopoietin 
A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Granulocyte Colony-Stimulating FactorInterleukin-3Recombinant Fusion Proteins
myelopoietin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
model of radiation-induced myelosuppression stimulates multilineage hematopoietic recovery in a nonhuman primate Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist,
2008
2008
Novel biomarkers--the long march from bench to bedside.
In recent years, a deeper understanding of the pathobiology of atherothrombosis as the underlying mechanism of acute coronary… 
2001
2001
What's in a name . . . apropos MPO
Science is an communal endeavor of vast complexity, subtlety and importance to the human commonweal. As such, it behoves… 
2000
2000
Erratum: Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasma (Cytotherapy (2000) 2 (85-94…
1999
1999
USAN Council. List No.421. New names. Leridistim.